Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04034498 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Multicenter, International, Follow-up Study to Monitor the Efficacy and Safety of the Occlutech® PmVSD Occluder in Patients With Perimembranous Ventricular Septal Defects

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated January 16, 2026 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study sites: 5 to 8v6
  2. Enrollment target: 200 to 50
    • Trial status: Recruiting to Active, Not Recruiting
    • Study sites: 7 to 5
    v5
  3. Study sites: 8 to 7v4
  4. Site details revised at 2 of 8 sitesv3
  5. Study sites: 1 to 8v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The objective of this registry is to gain more insight on the clinical use of the Occlutech perimembranous VSD occluder.
Trial Details
NCT Number NCT04034498
Lead Sponsor Occlutech International AB
Conditions
(from sponsor)		 Perimembranous Ventricular Septal Defect
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov